Study findings support the monitoring and management of iron status in patients with early stages of chronic kidney disease (CKD).

Dr Sanjay Agrawal applies for patent for a specialized formulation for CKD related nutritional deficiencies: Shardul Nautiyal, Mumbai Wednesday, April 2, 2025, 08:00 Hrs [IST] Dr ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...

Modus Therapeutics Holding AB (“Modus”) today announces that the company has secured access to bridge financing of up to SEK 5.0 million from its largest shareholder, Karolinska Development AB. The ...

William Blair reissued their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report ...

Elizabeth Knowles’ baby sister, Jermeek Rolle, is her hero – literally. She donated a kidney to her sister who was in end ...

Anemia is highly prevalent in patients with ... human erythropoietin therapy in anemic patients with chronic kidney disease and concomitant heart disease have demonstrated a reduction in left ...

Some drugs are known as nephrotoxic, which means that their effects can cause damage to the kidneys. Drugs such as certain ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Charles Schwab Investment Management Inc. raised its stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 3.2% during the fourth quarter, HoldingsChannel reports. The firm owned ...

A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...